Trading Members of the Exchange are hereby informed that effective from Thursday, 20th July, 2017 the equity shares of Artemis Global Life Science Limited shall be listed and admitted to dealings on the Exchange in the list of T Group of Securities. Further in terms of SEBI circular No. CIR/MRD/DP/02/2012 dated January 20, 2012; the scrip will be in Trade-for-Trade segment for 10 trading days.
Members are requested to note that the above security will be a part of special pre-open session for IPO and Other category of scrip’s as per SEBI circular no. CIR/MRD/DP/01/2012 & CIR/MRD/DP/02/2012 dated January 20, 2012.
For further information on SPOS, the trading members are requested to refer to the Exchange’s notice no. 20120216-29 on Enabling Special Pre-open Session for IPO’s & Relisted Scrips. For any clarification on SPOS, the trading members may please contact the Helpdesk on 022-6136 3100 / 6136 3171.
|
Name of the Company
|
:
|
|
|
Registered Office
|
:
:
:
:
:
:
|
414/1 4th Floor,
DDA Commercial Complex
District Centre
Janakpuri, New Delhi 110058.
Tel: +91-11-25617291
+91-124-4262305
Fax: +91-124-4262306
Email ID : investor@aglsl.in
Website :- www.aglsl.in
|
|
Company Secretary & Compliance Officer
|
:
:
|
Mr. Anuj Sood
Email ID: csanujsood@aglsl.in
|
|
Securities
|
:
|
64232250 Equity shares of Rs.2/- allotted pursuant to Scheme of Amalgamation
|
|
Distinctive numbers
|
:
|
01 to 914694
1068445 to 1068944
1351945 to 1353344
1369645 to 1380094
2870095 to 2873544
2886745 to 66188500
|
|
Scrip Code
|
:
|
540616
|
|
Group
|
:
|
T
|
|
Market Lot
|
:
|
1
|
|
Face Value & Paid up value
|
:
|
Rs.2/- each fully paid
|
|
Scrip ID on BOLT System
|
:
|
ARTEMIS
|
|
Abbreviated name on BOLT
|
:
|
ARTEMIS
|
|
ISIN No.
|
:
|
INE517U01013
|
|
Lock-in
|
:
|
N/A
|
| |
|
|
|
1. The brief particulars of the Scheme of Amalgamation are as mentioned below:
a) The Scheme of Amalgamation of the Company was approved by the National Company Law Tribunal, Delhi Bench and Hon’ble High Court of Kerala vide its Order dated 01/03/2017 and 08/08/2016 respectively.
b) Appointed Date: 01/04/2016
c) Effective date: 08/03/2017
d) Date of Allotment: 30/03/2017
e) Pursuant to the Scheme of Arrangement relating to Demerger of Medicare and Health Undertaking of PTL Enterprises Limited into Artemis Global Life Sciences Limited as sanctioned by the Delhi Bench of the Hon’ble National Company Law Tribunal and Hon’ble High Court of Kerala, Artemis Global Life Science Limited has issued to the shareholders of PTL Enterprises Limited, 1 equity share of Rs. 2/- each of Artemis Global Life Science Limited for every 1(ONE) equity Share of Rs. 2/- each held in PTL Enterprises Limited. The issued, subscribed and paid-up equity capital of the company post amalgamation is Rs. 132377000/- Equity shares of Rs.2/- consisting of 66188500 Equity shares Rs.2/- each.
2. As per Exchange Notice No. 20170320-3 dated 20th March 2017, PTL Enterprises Ltd. had fixed Record date as 29/03/2017 for giving effect to the Scheme of Amalgamation.
3. The Information Memorandum containing all the information about the company can be viewed at http://www.bseindia.com/corporates/soa.aspx?expandable=3
4. The name and address of the registrar and share transfer agent of the company is as mentioned below:
Alankit Assignments Limited
Regd Office: 205-208, Anarkali Complex,
Jhandewalan Extension, New Delhi-110055
Corp Office: 1E/13 Alankit Heights Jhandewalan
Extension New Delhi -110 055
Phone: +91-11-42541234 / 23541234/+91-11- 42541201
Email: info@alankit.com
Website: www.alankit.com
1. The shareholding pattern of the company post scheme of arrangement is enclosed as Annexure A.
Nitin Pujari
Manager |